The Latest Analyst Ratings for Guardant Health
Portfolio Pulse from Benzinga Insights
Over the past 3 months, 7 analysts have published their opinion on Guardant Health (NASDAQ:GH) stock. The average price target for the stock is $44.86, a decrease of 3.32% from the previous average price target of $46.40. The majority of the ratings are bullish.
October 20, 2023 | 2:00 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Analysts have a generally bullish outlook on Guardant Health, with an average price target of $44.86. This represents a decrease from the previous target.
The majority of analysts have a bullish outlook on Guardant Health, which is likely to have a positive impact on the stock price. However, the decrease in the average price target could indicate a potential slowdown in the stock's growth.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100